This book chapter advances SDG3 Good Health and Wellbeing and SDG10 Reducing Inequalities by reviewing the steps needed to develop and implement a nutritional plan for patients with neurologic disorders.
Elsevier,
Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics, Volume , 1 January 2021
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced inequalities by showing the effectiveness of neural mobilization on pain and disability in individuals with musculoskeletal disorders.
Building and Environment will host a series of free webinars on COVID-19 Control, with the first webinar featuring 2 presentations from experts in the field:
1. Risk of Airborne COVID-19 Virus Transmissions in Airliner Cabins, presented by Qingyan “Yan” Chen, James G. Dwyer Professor of Mechanical Engineering, Purdue University, USA
2. Mitigating COVID-19 at Public Spaces, presented by John Zhai, Professor of Architectural Engineering, University of Colorado, Boulder and Keith Trace, Senior Director, Global Operations Services, Engineering and Facilities Management, Marriott International
This is a special issue on food systems for children and adolescents with research on food marketing, nutrition and sustaining healthy diets and food supply chains.
This Article supports SDG 3 by summarising global, regional, and national estimates of the burden of tracheal, bronchus, and lung cancer and larynx cancer and their attributable risks from 1990 to 2019, and highlighting the importance of preventive measures such as smoking control interventions, air quality management programmes focused on major air pollution sources, and widespread access to clean energy.
Women represent ⅔ of the cases of Alzheimer's disease (AD). Current research has focused on differential risks to explain higher rates of AD in women.
Using event-related potentials (ERPs) might help identify early neural changes indicative of future cognitive decline, offering an accessible and affordable alternative to other neuroimaging methods
A good study that looked at the mathematical method to evaluate the drug resistant of virus emergence using HIV/AIDS treatment cases.
Imbalances in redox homeostasis can result in oxidative stress, which is implicated in various pathological conditions including the fatal neuromuscular disease Duchenne Muscular Dystrophy (DMD). DMD is a complicated disease, with many druggable targets at the cellular and molecular level including calcium-mediated muscle degeneration; mitochondrial dysfunction; oxidative stress; inflammation; insufficient muscle regeneration and dysregulated protein and organelle maintenance. Previous investigative therapeutics tended to isolate and focus on just one of these targets and, consequently, therapeutic activity has been limited. Nuclear erythroid 2-related factor 2 (Nrf2) is a transcription factor that upregulates many cytoprotective gene products in response to oxidants and other toxic stressors. Unlike other strategies, targeted Nrf2 activation has the potential to simultaneously modulate separate pathological features of DMD to amplify therapeutic benefits. Here, we review the literature providing theoretical context for targeting Nrf2 as a disease modifying treatment against DMD.
